Inventor · disambiguated record
Dmitry Koltun
Also filed as: KOLTUN DMITRY
36 granted patents·14 pending applications·277 citations·filing 2003–2024
97Inventor score
Files withGILEAD SCIENCES INC17GILEAD PALO ALTO INC10CV THERAPEUTICS INC6KOLTUN DMITRY6CORKEY BRITTON KENNETH3
Top patents by PatentIndex Score
50 records- 0197US11939347B21′-cyano nucleoside analogs and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Mar 26, 2024·7 cites·45 claims
- 0296US11179397B2Imidazopyrimidine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·23 cites·13 claims
- 0395US7625881B2Prodrugs of A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2006·Granted Dec 1, 2009·31 cites·17 claims
- 0494US9371329B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2014·Granted Jun 21, 2016·26 cites·2 claims
- 0594US8952034B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2010·Granted Feb 10, 2015·29 cites·18 claims
- 0694US8586732B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Nov 19, 2013·29 cites·35 claims
- 0792US8697863B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Apr 15, 2014·13 cites·11 claims
- 0891US9676760B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 13, 2017·7 cites·2 claims
- 0991US9598435B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 21, 2017·9 cites·13 claims
- 1090US9193694B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Nov 24, 2015·11 cites·11 claims
- 1189US7579504B2ABCA1 elevating compoundsGILEAD SCIENCES INC·Filed 2006·Granted Aug 25, 2009·8 cites·24 claims
- 1287US7662819B2Pteridinone derivatives for use as stearoyl CoA desaturase inhibitorsGILEAD PALO ALTO INC·Filed 2007·Granted Feb 16, 2010·15 cites·17 claims
- 1384US9403782B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Aug 2, 2016·4 cites·10 claims
- 1483US8703759B2Fused heterocyclic compounds as ion channel modulatorsKOBAYASHI TETSUYA·Filed 2011·Granted Apr 22, 2014·7 cites·25 claims
- 1583US6900219B2ABCA-1 elevating compoundsCV THERAPEUTICS INC·Filed 2003·Granted May 31, 2005·23 cites·48 claims
- 1682US11040033B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2018·Granted Jun 22, 2021·1 cites·22 claims
- 1782US9079901B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2014·Granted Jul 14, 2015·5 cites·24 claims
- 1882US8962610B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Feb 24, 2015·6 cites·21 claims
- 1981US12404289B21′-cyano nucleoside analogs and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Sep 2, 2025·0 cites·11 claims
- 2081US9115096B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Aug 25, 2015·5 cites·13 claims
- 2181US7893066B2Pyridol[2,3-B]pyrazinones for use as stearoyl CoA desaturase inhibitorsGILEAD PALO ALTO INC·Filed 2008·Granted Feb 22, 2011·5 cites·22 claims
- 2281US7423045B2ABCA1 elevating compoundsCV THERAPEUTICS INC·Filed 2006·Granted Sep 9, 2008·2 cites·20 claims
- 2380US8143249B2Prodrugs of A2B adenosine receptor antagonistsKALLA RAO·Filed 2011·Granted Mar 27, 2012·4 cites·10 claims
- 2480US7407960B2Substituted heterocyclic compoundsCV THERAPEUTICS INC·Filed 2006·Granted Aug 5, 2008·3 cites·11 claims
- 2576US7432276B2ABCA1 elevating compoundsCV THERAPEUTICS INC·Filed 2006·Granted Oct 7, 2008·1 cites·15 claims
- 2672US2010113461A1Substituted heterocyclic compoundsGILEAD PALO ALTO INC·Filed 2009·Application pending·0 cites
- 2769US7732453B2Pyrido[2,3-B] pyrazin-3(4H)-ones for use as stearoyl CoA desaturase inhibitorsGILEAD PALO ALTO INC·Filed 2007·Granted Jun 8, 2010·1 cites·21 claims
- 2868US8088792B2Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitorsKOLTUN DMITRY·Filed 2009·Granted Jan 3, 2012·1 cites·18 claims
- 2967US2025026745A117-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereofBLUEJAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3066US2010056538A1Pro-drugs of A2B Adenosine Receptor AntagonistsGILEAD PALO ALTO INC·Filed 2009·Application pending·0 cites
- 3166US2024182472A1Indazole pyridone compounds and uses thereofBLUEJAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3265US2022241281A1Imidazopyrimidine DerivativesGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 3364US7125876B2Substituted heterocyclic compoundsCV THERAPEUTICS INC·Filed 2003·Granted Oct 24, 2006·1 cites·13 claims
- 3463US11229638B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2018·Granted Jan 25, 2022·0 cites·7 claims
- 3560US2008293757A1Abca1 elevating compoundsABELMAN MATTHEW·Filed 2008·Application pending·0 cites
- 3658US7601721B2Substituted heterocyclic compoundsGILEAD PALO ALTO INC·Filed 2007·Granted Oct 13, 2009·0 cites·17 claims
- 3755US7271169B2Substituted heterocyclic compoundsCV THERAPEUTICS INC·Filed 2005·Granted Sep 18, 2007·0 cites·17 claims
- 3851US9682998B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 20, 2017·0 cites·12 claims
- 3951US8912190B2Substituted heterocyclic compoundsGILEAD SCIENCES INC·Filed 2012·Granted Dec 16, 2014·0 cites·7 claims
- 4051US2010267748A1HETEROCYCLIC COMPOUNDS USEFUL AS STEAROYL CoA DESATURASE INHIBITORSGILEAD PALO ALTO INC·Filed 2009·Application pending·0 cites
- 4149US2010267752A13-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSGILEAD PALO ALTO INC·Filed 2009·Application pending·0 cites
- 4246US2009253704A1PYRROLOTRIAZINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSKOLTUN DMITRY·Filed 2009·Application pending·0 cites
- 4344US2009253693A12H-BENZO[b][1,4]OXAZIN-3(4H)-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSKOLTUN DMITRY·Filed 2009·Application pending·0 cites
- 4443US2009105283A13-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSKOLTUN DMITRY·Filed 2008·Application pending·0 cites
- 4542US10100058B2Fused heterocyclic compounds as CaM kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Granted Oct 16, 2018·0 cites·33 claims
- 4642US9695192B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Jul 4, 2017·0 cites·7 claims
- 4742US2012065227A1TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSKOLTUN DMITRY·Filed 2011·Application pending·0 cites
- 4839US2008255161A13-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSKOLTUN DMITRY·Filed 2008·Application pending·0 cites
- 4939US2010113463A1PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSGILEAD PALO ALTO INC·Filed 2010·Application pending·0 cites
- 5035US8148376B23, 4-dihydroquinoxalin-2(1H)-ones for use as stearoyl CoA desaturase inhibitorsCHISHOLM JEFFREY·Filed 2010·Granted Apr 3, 2012·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Dmitry Koltun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →